Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized prospective single center study.

Trial Profile

Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized prospective single center study.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jan 2012

At a glance

  • Drugs Meropenem (Primary)
  • Indications Bacterial infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jan 2012 Additional trial identifier (26147641), trial centre and investigator identified and inclusion, exclusion criteria added as reported by ISRCTN: Current Controlled Trials.
    • 21 Jan 2012 Actual end date (Apr 2010) added as reported by ISRCTN: Current Controlled Trials
    • 21 Jan 2012 Actual initiation date (Oct 2007) added as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top